News
PRPO
5.27
-1.50%
-0.08
Weekly Report: what happened at PRPO last week (1209-1213)?
Weekly Report · 5d ago
Weekly Report: what happened at PRPO last week (1202-1206)?
Weekly Report · 12/09 12:16
Weekly Report: what happened at PRPO last week (1125-1129)?
Weekly Report · 12/02 12:16
Two Smaller Companies Worthy of Your "Attention"
NASDAQ · 11/25 19:31
Weekly Report: what happened at PRPO last week (1118-1122)?
Weekly Report · 11/25 12:04
Precipio Reports Improved Financials Amid Challenges
TipRanks · 11/19 04:01
Here are the major earnings after the close today
Seeking Alpha · 11/18 15:00
Weekly Report: what happened at PRPO last week (1111-1115)?
Weekly Report · 11/18 12:01
Weekly Report: what happened at PRPO last week (1104-1108)?
Weekly Report · 11/11 12:19
Precipio to Host Q3-2024 Shareholder Update Call
TipRanks · 11/07 11:36
Based on the provided financial report, the title of the article is: "PRECIPIO, INC. AND SUBSIDIARIES FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024
Press release · 11/07 02:30
Weekly Report: what happened at PRPO last week (1028-1101)?
Weekly Report · 11/04 12:15
Weekly Report: what happened at PRPO last week (1021-1025)?
Weekly Report · 10/28 12:04
Weekly Report: what happened at PRPO last week (1014-1018)?
Weekly Report · 10/21 11:58
Weekly Report: what happened at PRPO last week (1007-1011)?
Weekly Report · 10/14 12:38
Precipio expands Bloodhound MPN panel by adding CALR mutation subtyping
TipRanks · 10/08 14:05
Precipio Announces The Launch Of A New Version Of Its Bloodhound MPN Panel That Is Now Able To Distinguish Between CALR Type 1 And Type 2 Mutations
Benzinga · 10/08 14:04
Weekly Report: what happened at PRPO last week (0930-1004)?
Weekly Report · 10/07 12:23
Weekly Report: what happened at PRPO last week (0923-0927)?
Weekly Report · 09/30 12:14
Weekly Report: what happened at PRPO last week (0916-0920)?
Weekly Report · 09/23 12:12
More
Webull provides a variety of real-time PRPO stock news. You can receive the latest news about Precipio Inc through multiple platforms. This information may help you make smarter investment decisions.
About PRPO
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Company’s technologies include HemeScreen and IV-Cell. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its technology enables testing to be completed in one rapid scanning process. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.